0.0001
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
726.0000
913.0000
2,218.0000
4,147.0000
Cost of Revenue
873.0000
1,106.0000
1,670.0000
2,909.0000
Gross Profit
-57.0000
-103.0000
548.0000
1,238.0000
Operating Expense
1,066.0000
1,139.0000
1,727.0000
1,859.0000
Operating Income
-1,123.0000
-1,242.0000
-1,179.0000
-621.0000
Net Non Operating Interest Income Expense
-164.0000
-191.0000
-194.0000
-175.0000
Other Income Expense
172.0000
25.0000
912.0000
2.0000
Pretax Income
852.0000
-1,408.0000
-461.0000
-794.0000
Tax Provision
2.0000
2.0000
2.0000
2.0000
Net Income Common Stockholders
850.0000
-1,410.0000
-463.0000
-796.0000
Diluted NI Available to Com Stockholders
850.0000
-1,410.0000
-463.0000
-796.0000
Basic EPS
0.02
-0.03
-0.01
-0.02
Diluted EPS
0.02
-0.03
-0.01
-0.02
Basic Average Shares
48,099.5980
48,017.6540
42,761.0650
35,558.1050
Diluted Average Shares
48,099.5980
48,017.6540
42,761.0650
35,558.1050
Total Operating Income as Reported
-1,123.0000
-1,242.0000
-1,179.0000
-621.0000
Total Expenses
1,939.0000
2,245.0000
3,397.0000
4,768.0000
Net Income from Continuing & Discontinued Operation
850.0000
-1,410.0000
-463.0000
-796.0000
Normalized Income
-2,177.8756
-1,410.0000
-698.0000
-796.0000
Interest Income
--
3.0000
--
--
Interest Expense
167.0000
194.0000
194.0000
175.0000
Net Interest Income
-164.0000
-191.0000
-194.0000
-175.0000
EBIT
1,019.0000
-1,214.0000
-267.0000
-619.0000
EBITDA
1,065.0000
-1,163.0000
-199.0000
-540.0000
Reconciled Cost of Revenue
873.0000
1,106.0000
1,670.0000
2,909.0000
Reconciled Depreciation
46.0000
51.0000
68.0000
79.0000
Net Income from Continuing Operation Net Minority Interest
850.0000
-1,410.0000
-463.0000
-796.0000
Total Unusual Items Excluding Goodwill
3,035.0000
--
235.0000
--
Total Unusual Items
3,035.0000
--
235.0000
--
Normalized EBITDA
-1,970.0000
-1,163.0000
-434.0000
-540.0000
Tax Rate for Calcs
0.0000
--
--
--
Tax Effect of Unusual Items
7.1244
--
--
--
12/31/2020 - 2/1/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
D9Z.DU Clinica Baviera SA
32.30
+0.31%
D9Z.BE Clinica Baviera SA
32.30
-0.92%
ARYC Arrayit Corporation
0.0001
0.00%
CBAV.MC Clínica Baviera, S.A.
33.00
+1.54%
SHC Sotera Health Company
13.11
-2.09%
QGEN Qiagen N.V.
44.68
-1.28%
NEOG Neogen Corporation
12.36
-5.43%
LH Labcorp Holdings Inc.
232.00
-0.99%
GRAL GRAIL, Inc.
17.73
+0.40%